ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours-Reference-Cited by-同舟云学术

ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours

Published:2016-11 Issue: Volume:51 Page:56-64
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Coyle Christopher^ORCID,Cafferty Fay H.,Rowley Samuel,MacKenzie Mairead,Berkman Lindy,Gupta Sudeep,Pramesh C S,Gilbert Duncan,Kynaston Howard,Cameron David,Wilson Richard H.,Ring Alistair,Langley Ruth E.

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference45 articles.

1. Cancer Research UK. CancerStats - Cancer Statistics for the UK. In.

2. Aspirin and cancer risk: a quantitative review to 2011;Bosetti;Ann. Oncol.,2012

3. Association between aspirin use and mortality in breast cancer patients: a meta-analysis of observational studies;Zhong;Breast Cancer Res. Treat.,2015

4. Aspirin intake and survival after breast cancer;Holmes;J. Clin. Oncol.,2010

5. Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study;Fraser;Br. J. Cancer,2014

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer—Reply;JAMA;2024-09-05

2. Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer;JAMA;2024-09-05

3. The future of pharmacology and therapeutics of the arachidonic acid cascade in the next decade: Innovative advancements in drug repurposing;Frontiers in Pharmacology;2024-08-29

4. Exploring the Protective Role of Aspirin Use in Mitigating Colorectal Cancer (CRC) Metastasis;Journal of Clinical Gastroenterology;2024-07-17

5. A systematic methodology review of fluorescence-guided cancer surgery to inform the development of a core master protocol and outcome set;BMC Cancer;2024-06-07